Related Experiment Video
Updated: Jul 2, 2026
06:16
Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
Published on: August 9, 2024
Cost-effectiveness of B-type natriuretic peptide testing
1Department of Internal Medicine, University Hospital, Basel, Switzerland. chmueller@uhbs.ch
Congestive Heart Failure (Greenwich, Conn.)
|October 4, 2008
Summary
B-type natriuretic peptide (BNP) testing is cost-effective for diagnosing heart failure (HF) and screening for left ventricular systolic dysfunction. BNP guidance also appears to reduce rehospitalizations in chronic HF patients, indicating its value.
Area of Science:
- Cardiology
- Health Economics
Background:
- Heart failure (HF) diagnosis and management present significant healthcare challenges.
- Accurate and cost-effective diagnostic tools are crucial for optimal patient outcomes.
Purpose of the Study:
- To evaluate the cost-effectiveness of B-type natriuretic peptide (BNP) testing across various clinical indications.
- To determine the economic value of BNP testing in heart failure diagnosis, prognosis, and management.
Main Methods:
- Cost-effectiveness analysis of BNP testing compared to alternative diagnostic strategies.
- Review of existing literature and clinical data on BNP utility in different patient populations.
Main Results:
- BNP testing is cost-effective for screening asymptomatic left ventricular systolic dysfunction in populations with ≥1% prevalence.
- BNP testing demonstrates cost savings in the diagnosis of heart failure (HF).
- BNP testing is likely cost-effective for risk stratification in hospitalized HF patients and reducing rehospitalizations.
Conclusions:
- BNP testing offers significant cost-effectiveness in specific heart failure (HF) related indications.
- Further research is needed to establish cost-effectiveness for evolving BNP testing applications.
Related Concept Videos
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
01:27Transducer Mechanism: Enzyme-Linked Receptors
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include: